Laden.... Wacht alsjeblieft even.

Bedrijfsprofiel

Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (47.9%), Europe (24.7%), North America (24.4%) and other (3%).

Bron: Cofisem - laatste update: 16 Jan 2025
Bestuurders
Chief Executive Officer Pascal Houdayer
Deputy CEO Jean-Christophe Bayssat
Deputy CEO Thierry Boiron
Bron: Cofisem - laatste update: 16 Jan 2025
Kerncijfers
Millenium 2023 2022 2021 2020 2019
Net sales 493.248 534.239 455.201 513.582 557.123
Income from ordinary activities 493.249 534.240 455.202 513.584 557.125
Operating income 42.290 63.448 46.842 38.185 66.915
Cost of financial indebtedness net -6.271 -1.210 -231 -111 -373
Equity-accounted companies contribution to income
Net profit from discontinued activities
Net income 33.940 44.280 28.559 26.209 40.584
Net income (Group share) 35.827 44.673 28.556 26.209 40.630
Fiscal year end 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Length of fiscal year (month) 12 12 12 12 12
Currency & Unit EUR - thousands EUR - thousands EUR - thousands EUR - thousands EUR - thousands
Account Standards IFRS IFRS IFRS IFRS IFRS
Bron: Cofisem - laatste update: 16 Jan 2025
Aandeelhoudersinformatie
Boiron Développement 79,00 %
Other shareholders 20,00 %
Group-owned stock 1,00 %
Bron: Cofisem - laatste update: 16 Jan 2025

Adres

BOIRON

2 Avenue de l'Ouest Lyonnais
FR-69510 Messimy
France
Bron: Cofisem - laatste update: 16 Jan 2025

Contact

Fabrice REY
Telefoonnummer: +33 04 78 45 61 00
Bron: BOIRON - laatste update: 07 Jan 2025